MGV

Monsanto Growth Ventures (MGV) is the corporate venture capital arm of Monsanto, which is now a subsidiary of Bayer. MGV focuses on investing in early-stage to growth-stage companies across the life sciences, biotechnology, and agricultural technology sectors. The firm's portfolio includes a diverse range of companies developing innovative therapies, diagnostic tools, and digital health solutions, as well as advanced agricultural biologicals and precision farming technologies. MGV actively partners with its portfolio companies to accelerate the development and commercialization of breakthrough innovations that address global challenges in health and food security. Following Bayer's acquisition of Monsanto, MGV's activities have been integrated into the broader Leaps by Bayer investment platform.